Showing results (341-350 of 362) with videos related to

Sort By:
Pageof 37
Cell Host & Microbe|April 14, 2017
Defective HIV-1 Proviruses Are Expressed and Can Be Recognized by Cytotoxic T Lymphocytes, which Shape the Proviral LandscapeRoss A Pollack, R Brad Jones, Mihaela Pertea, et al.
Elife|February 27, 2023
Specific targeting of inflammatory osteoclastogenesis by the probiotic yeast <i>S. boulardii</i> CNCM I-745 reduces bone loss in osteoporosisMaria-Bernadette Madel, Julia Halper, Lidia Ibáñez, et al.
NAR Cancer|June 25, 2024
CRISPR-Cas9 for selective targeting of somatic mutations in pancreatic cancersSelina Shiqing K Teh, Kirsten Bowland, Eitan Halper-Stromberg, et al.
Neurology|April 25, 2018
Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of NeurologyAlexander Rae-Grant, Gregory S Day, Ruth Ann Marrie, et al.
The Journal of Clinical Investigation|May 15, 2026
Simultaneous CRISPR/Cas9-induced double-strand breaks are lethal in models of pancreatic cancerSelina Shiqing K Teh, Akhil Kotwal, Alexis Bennett, et al.
Neurology|April 25, 2018
Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of NeurologyAlexander Rae-Grant, Gregory S Day, Ruth Ann Marrie, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 18, 2013
HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized miceJoshua A Horwitz, Ariel Halper-Stromberg, Hugo Mouquet, et al.
The Journal of Experimental Medicine|November 12, 2014
Enhanced HIV-1 immunotherapy by commonly arising antibodies that target virus escape variantsFlorian Klein, Lilian Nogueira, Yoshiaki Nishimura, et al.
Network and Systems Medicine|May 14, 2021
Plasma Metabolomic Signatures of Chronic Obstructive Pulmonary Disease and the Impact of Genetic Variants on Phenotype-Driven ModulesLucas A Gillenwater, Katherine A Pratte, Brian D Hobbs, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|November 7, 2022
Prolonged, physiologically relevant nicotine concentrations in the airways of smokersCharles R Esther, Wanda K O'Neal, Neil E Alexis, et al.
Pageof 37